10-95058362-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000770.3(CYP2C8):āc.792C>Gā(p.Ile264Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0453 in 1,613,150 control chromosomes in the GnomAD database, including 1,876 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.035 ( 120 hom., cov: 32)
Exomes š: 0.046 ( 1756 hom. )
Consequence
CYP2C8
NM_000770.3 missense
NM_000770.3 missense
Scores
1
5
12
Clinical Significance
Conservation
PhyloP100: -0.579
Genes affected
CYP2C8 (HGNC:2622): (cytochrome P450 family 2 subfamily C member 8) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, benzo(a)pyrene, 7-ethyoxycoumarin, and the anti-cancer drug taxol. This gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0040852427).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0507 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP2C8 | NM_000770.3 | c.792C>G | p.Ile264Met | missense_variant | 5/9 | ENST00000371270.6 | NP_000761.3 | |
CYP2C8 | NM_001198853.1 | c.582C>G | p.Ile194Met | missense_variant | 5/9 | NP_001185782.1 | ||
CYP2C8 | NM_001198855.1 | c.582C>G | p.Ile194Met | missense_variant | 6/10 | NP_001185784.1 | ||
CYP2C8 | NM_001198854.1 | c.486C>G | p.Ile162Met | missense_variant | 4/8 | NP_001185783.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP2C8 | ENST00000371270.6 | c.792C>G | p.Ile264Met | missense_variant | 5/9 | 1 | NM_000770.3 | ENSP00000360317.3 |
Frequencies
GnomAD3 genomes AF: 0.0355 AC: 5397AN: 152042Hom.: 120 Cov.: 32
GnomAD3 genomes
AF:
AC:
5397
AN:
152042
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0375 AC: 9410AN: 251022Hom.: 217 AF XY: 0.0374 AC XY: 5069AN XY: 135658
GnomAD3 exomes
AF:
AC:
9410
AN:
251022
Hom.:
AF XY:
AC XY:
5069
AN XY:
135658
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0463 AC: 67688AN: 1460990Hom.: 1756 Cov.: 31 AF XY: 0.0456 AC XY: 33142AN XY: 726798
GnomAD4 exome
AF:
AC:
67688
AN:
1460990
Hom.:
Cov.:
31
AF XY:
AC XY:
33142
AN XY:
726798
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0354 AC: 5394AN: 152160Hom.: 120 Cov.: 32 AF XY: 0.0345 AC XY: 2568AN XY: 74400
GnomAD4 genome
AF:
AC:
5394
AN:
152160
Hom.:
Cov.:
32
AF XY:
AC XY:
2568
AN XY:
74400
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
182
ALSPAC
AF:
AC:
186
ESP6500AA
AF:
AC:
57
ESP6500EA
AF:
AC:
471
ExAC
AF:
AC:
4687
Asia WGS
AF:
AC:
22
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
CYP2C8-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 07, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
CYP2C8 POLYMORPHISM Benign:1
Benign, no assertion criteria provided | literature only | OMIM | Jun 20, 2018 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;.;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
.;D;D;D;D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
.;.;.;M;.
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D;.;D;.
REVEL
Uncertain
Sift
Uncertain
.;D;.;D;.
Sift4G
Uncertain
D;D;D;D;D
Polyphen
0.99
.;.;.;D;.
Vest4
MPC
0.18
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at